The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Polewaczyk James F since 2008.
This trader's CIK number is 1389046.
At the time of last reporting, Polewaczyk James F was the Executive Vice President of Idexx Laboratories Inc /de. (stock ticker symbol IDXX).
Also see all insider trading activities at Idexx Laboratories Inc /de.
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2024 | IDXX | 0 | $0 | 8,104 | $4,527,850 | 8,104 | $2,525,895 |
| 2023 | IDXX | 0 | $0 | 34,545 | $17,760,128 | 29,379 | $5,280,001 |
| 2022 | IDXX | 0 | $0 | 0 | $0 | 781 | $0 |
| 2021 | IDXX | 0 | $0 | 14,595 | $8,531,375 | 12,465 | $778,646 |
| 2020 | IDXX | 0 | $0 | 16,264 | $4,859,292 | 18,373 | $1,215,498 |
| 2013 | IDXX | 0 | $0 | 0 | $0 | 1,318 | $0 |
| 2012 | IDXX | 0 | $0 | 5,459 | $518,659 | 7,306 | $249,257 |
| 2011 | IDXX | 0 | $0 | 17,236 | $1,337,841 | 20,522 | $950,852 |
| 2010 | IDXX | 0 | $0 | 0 | $0 | 1,374 | $0 |
| 2009 | IDXX | 0 | $0 | 0 | $0 | 974 | $0 |
| 2008 | IDXX | 0 | $0 | 0 | $0 | 716 | $0 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2024-03-06 | IDXX | Option Ex | 8,104 | 311.69 | 2,525,895 |
| 2024-03-06 | IDXX | Sale | 8,104 | 558.72 | 4,527,850 |
| 2023-12-07 | IDXX | Option Ex | 11,636 | 247.86 | 2,884,098 |
| 2023-12-07 | IDXX | Sale | 11,636 | 521.77 | 6,071,269 |
| 2023-08-29 | IDXX | Option Ex | 16,909 | 141.69 | 2,395,903 |
| 2023-08-29 | IDXX | Sale | 22,909 | 510.23 | 11,688,859 |
| 2023-02-14 | IDXX | Option Ex | 834 | .00 | 0 |
| 2022-02-14 | IDXX | Option Ex | 781 | .00 | 0 |
| 2021-11-29 | IDXX | Sale | 4,595 | 633.00 | 2,908,635 |
| 2021-05-28 | IDXX | Option Ex | 10,000 | 67.85 | 678,500 |
| 2021-05-28 | IDXX | Sale | 10,000 | 562.27 | 5,622,740 |
| 2021-02-25 | IDXX | Option Ex | 1,476 | 67.85 | 100,146 |
| 2021-02-14 | IDXX | Option Ex | 989 | .00 | 0 |
| 2020-05-11 | IDXX | Option Ex | 16,264 | 68.59 | 1,115,596 |
| 2020-05-11 | IDXX | Sale | 16,264 | 298.78 | 4,859,292 |
| 2020-02-27 | IDXX | Option Ex | 1,256 | 79.54 | 99,902 |
| 2020-02-14 | IDXX | Option Ex | 853 | .00 | 0 |
| 2013-02-14 | IDXX | Option Ex | 1,318 | .00 | 0 |
| 2012-08-31 | IDXX | Option Ex | 5,459 | 45.66 | 249,257 |
| 2012-08-31 | IDXX | Sale | 5,459 | 95.01 | 518,659 |
| 2012-02-14 | IDXX | Option Ex | 1,847 | .00 | 0 |
| 2011-02-17 | IDXX | Option Ex | 18,868 | 50.40 | 950,852 |
| 2011-02-17 | IDXX | Sale | 17,236 | 77.62 | 1,337,841 |
| 2011-02-14 | IDXX | Option Ex | 1,654 | .00 | 0 |
| 2010-02-14 | IDXX | Option Ex | 1,374 | .00 | 0 |
| 2009-02-14 | IDXX | Option Ex | 974 | .00 | 0 |
| 2008-02-14 | IDXX | Option Ex | 716 | .00 | 0 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Polewaczyk James F (Executive Vice President of Idexx Laboratories Inc /de at the time of this reporting) see the Securities and Exchange Commission (SEC) website.